WORKING TOWARDS LAUNCH IN 2022
Gyder Surgical is committed to developing easy-to-use surgical navigation systems that integrate seamlessly with the clinician’s workflow.
Our first product, the GYDER® Hip Navigation System, is in the final stages of an extensive test program in preparation for submitting pre-market approval applications to the Australian Therapeutic Goods Administration (TGA) and the US Food and Drugs Administration (FDA).
Gyder Surgical’s technology is protected by an Intellectual Property portfolio that includes:
- three patent families covering the technology granted in 18 countries to date, including the USA, Australia and nominated EU jurisdictions
- a fourth patent family covering new inventions at the PCT stage.
- proprietary secrets in data acquisition and data processing algorithms used in the GYDER® Navigation Unit
- several trademarks and logos.
Gyder Surgical acknowledges the support of its private investors during the development of the GYDER® System and for the grant support provided by the:
Gyder Surgical is developing regulatory submissions to the Australian Therapeutic Goods Administration and the US Food and Drugs Administration.
Gyder is working towards launching the GYDER Hip Navigation System in 2022.
GET IN TOUCH
Want to know more us? Get in touch today, we'd love to hear from you.